ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Execs Go Shopping While Others Cash Out

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

A flurry of fresh insider filings landed this week, revealing sharp divergence between buyers and sellers at the top.

The boldest buyer was Florentino Perez Rodriguez, Chairman and CEO of ACS. He filed this week disclosing three separate purchases totalling roughly $50M between July 29 and July 31. He bought 400,000 shares at prices between €107 and €111. That level of personal commitment from a sitting CEO is rare and hard to ignore.

BSX CEO Michael Mahoney also joined the buyers. He filed on August 5 disclosing a $9M purchase of 186,240 Boston Scientific shares on August 3 at around $48.33. The stock has been a strong performer, making this a notable bet on continued momentum.

CSGP founder and CEO Andrew Florance filed a $2.5M purchase of CoStar Group shares on August 5. He bought 83,300 shares at $29.89. Founder-CEOs buying near multi-year lows tend to attract attention.

On the sell side, NXT CEO Simon Wolfson filed on August 7 disclosing a $31.7M sale of NEXT plc shares. Two insiders at NXT sold a combined $42M worth of stock this week. ILMN board member Keith Meister also disclosed a $33M sale of Illumina shares filed August 6.

LTH saw three insiders file combined sales of $24.5M this week, while MHK recorded three separate sellers offloading over $8.5M in Mohawk Industries stock.

This is not financial advice.

Stocks in this article

How this article was generated

Generated
9 Aug 2026, 04:10
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.